Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the BMT CTN 0401 trial
一项比较利妥昔单抗/卡莫司汀、依托泊苷、阿糖胞苷和美法仑(BEAM)方案与碘-131托西莫单抗/BEAM方案联合自体造血干细胞移植治疗复发性弥漫性大B细胞淋巴瘤的III期随机研究:BMT CTN 0401试验结果
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2012.45.9453
Vose, Julie M; Carter, Shelly; Burns, Linda J; Ayala, Ernesto; Press, Oliver W; Moskowitz, Craig H; Stadtmauer, Edward A; Mineshi, Shin; Ambinder, Richard; Fenske, Timothy; Horowitz, Mary; Fisher, Richard; Tomblyn, Marcie
B细胞
发育与干细胞
淋巴瘤
干细胞
细胞生物学
免疫/内分泌